Skip to content
Back to PBYI

Puma Biotechnology, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
17
Purchases
0
Sales
17
Purchase value
$0.00
Sale value
$2.14M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Michael Patrick MillerDirector
4
Filed Nov 13, 2026Period of report Nov 11, 20260001437749-26-036984
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 11, 2026
Common StockF115,000$8.0971$121.46K66,000Direct
Filing footnotes · 1
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.04 to $8.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Troy Edward WilsonDirector
4Rule 10b5-1 plan disclosed
Filed Sep 16, 2026Period of report Sep 14, 20260001437749-26-030597
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 14, 2026
Common StockF15,000$9.10$45.50K54,750Direct
Filing footnotes · 1
  1. F1Adoption date of referenced 10b5-1(c) plan is: 06-15-2026
Open on SEC EDGAR
Alessandra CesanoDirector
4Rule 10b5-1 plan disclosed
Filed Sep 16, 2026Period of report Sep 14, 20260001437749-26-030593
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 14, 2026
Common StockF1F262,150$9.123$566.99K56,700Direct
Filing footnotes · 3
  1. F1Adoption date of referenced 10b5-1(c) plan is: 06-15-2026
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.2, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3The Stock Option is fully vested.
Open on SEC EDGAR
Alan H AuerbachDirector · President and CEO · 10% owner
4Rule 10b5-1 plan disclosed
Filed Jul 8, 2026Period of report Jul 6, 20260001437749-26-023079
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common StockF144,058$8.263$364.05K7,261,671Direct
Filing footnotes · 1
  1. F1Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020.
Open on SEC EDGAR
Douglas M HuntSee Remarks
4Rule 10b5-1 plan disclosed
Filed Jul 8, 2026Period of report Jul 6, 20260001437749-26-023078
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common StockF18,460$8.263$69.90K196,841Direct
Filing footnotes · 1
  1. F1Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.
Open on SEC EDGAR
Maximo F NouguesChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 8, 2026Period of report Jul 6, 20260001437749-26-023077
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common StockF19,386$8.263$77.56K230,637Direct
Filing footnotes · 1
  1. F1Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.
Open on SEC EDGAR
Troy Edward WilsonDirector
4Rule 10b5-1 plan disclosed
Filed Jun 15, 2026Period of report Jun 11, 20260001437749-26-020709
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 12, 2026
Common StockF2F310,800$7.1989$77.75K59,750Direct
Filing footnotes · 3
  1. F1Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
  2. F2Adoption date of referenced 10b5-1(c) plan is: 03-12-2025
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Brian M StuglikDirector
4Rule 10b5-1 plan disclosed
Filed Jun 15, 2026Period of report Jun 11, 20260001437749-26-020708
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 12, 2026
Common StockF2F38,100$7.1989$58.31K113,858Direct
Filing footnotes · 3
  1. F1Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
  2. F2Adoption date of referenced 10b5-1(c) plan is: 03-12-2025
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Adrian SenderowiczDirector
4Rule 10b5-1 plan disclosed
Filed Jun 15, 2026Period of report Jun 11, 20260001437749-26-020706
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 12, 2026
Common StockF2F327,000$7.1967$194.31K27,000Direct
Filing footnotes · 3
  1. F1Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
  2. F2Adoption date of referenced 10b5-1(c) plan is: 03-12-2025
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
JAY M MoyesDirector
4Rule 10b5-1 plan disclosed
Filed Jun 15, 2026Period of report Jun 11, 20260001437749-26-020704
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 12, 2026
Common StockF2F322,000$7.218$158.80K58,322Direct
Filing footnotes · 3
  1. F1Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
  2. F2Adoption date of referenced 10b5-1(c) plan is: 03-12-2025
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Allison DorvalDirector
4Rule 10b5-1 plan disclosed
Filed Jun 15, 2026Period of report Jun 11, 20260001437749-26-020703
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 12, 2026
Common StockF2F311,610$7.1989$83.58K90,780Direct
Filing footnotes · 3
  1. F1Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.
  2. F2Adoption date of referenced 10b5-1(c) plan is: 03-12-2025
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Open on SEC EDGAR
Alan H AuerbachDirector · President and CEO · 10% owner
4Rule 10b5-1 plan disclosed
Filed Jan 8, 2026Period of report Jan 6, 20260001437749-26-000924
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 7, 2026
Common StockF118,012$5.879$105.89K7,145,951Direct
SaleJan 6, 2026
Common StockF116,938$5.844$98.99K7,163,963Direct
Filing footnotes · 1
  1. F1Adoption date of referenced 10b5-1(c) plan is: 12-17-2020
Open on SEC EDGAR
Douglas M HuntSee Remarks
4Rule 10b5-1 plan disclosed
Filed Jan 8, 2026Period of report Jan 6, 20260001437749-26-000922
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 7, 2026
Common StockF15,014$5.879$29.48K155,907Direct
SaleJan 6, 2026
Common StockF13,973$5.844$23.22K160,921Direct
Filing footnotes · 1
  1. F1Adoption date of referenced 10b5-1(c) plan is: 12-14-2020
Open on SEC EDGAR
Maximo F NouguesChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jan 8, 2026Period of report Jan 6, 20260001437749-26-000921
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 7, 2026
Common StockF16,405$5.879$37.65K193,284Direct
SaleJan 6, 2026
Common StockF14,540$5.844$26.53K199,689Direct
Filing footnotes · 1
  1. F1Adoption date of referenced 10b5-1(c) plan is: 12-14-2020
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.